Stories of Technology, Innovation, & Entrepreneurship in the Southeast

Knoxville Business News Tennessee Mountain Scenery Background
July 08, 2024 | Tom Ballard

Southeast Shoutouts | It’s all from North Carolina

From Charlotte to Greensboro and Morrisville, the Tar Heel State is hopping.

From Charlotte, NC:

Applications are being accepted through August 2 for the fall cohort of RevTech Labs. It is a 12-week, hybrid program for start-ups in the financial and insurance technology markets. According to this recent article in WRAL TechWire, the program initially provides $20,000 to $120,000 in dilutive funding based on the companies’ individual needs. After graduating later this year, alums will have the opportunity to attract follow-on investments through the RevTech Labs Capital fund.

The ideal start-up would be post-revenue with a developed minimum viable product in fintech, insurtech or business-to-business/software-as-a-service solutions. The program targets pre-seed to Series A stage companies that have raised $300,000 to $2 million in capital. It also prioritizes underrepresented founders, who comprised 87 percent of last fall’s cohort.

From Morrisville, NC:

Triangle Inno reports that the largest cohort of entrepreneurs to date presented their five-minute business pitches at the GRO Incubator Demo Day held recently in Morrisville, a town in the same county as Raleigh.

The 14 start-ups, part of the GRO7 cohort, spanned everything from technology to life sciences. They had just completed 12 weeks of intensive entrepreneurial training through the Council of Economic Development (CED). During the program, each start-up was matched with a coach who brought years of business development experience to the table.

From Greensboro, NC:

Claradele Pharmaceuticals, a Greenville, NC start-up developing a unique immunotherapy for metastatic melanoma, won the 2024 “NCBiotech Venture Challenge” and a $40,000 cash prize.

The selection of the company culminated a months-long grooming process for North Carolina’s freshest life sciences start-ups that ended with the competition during the sold-out Triad BioNight at the Grandover Resort in Greensboro.

Claradele is developing a treatment targeting a disease that occurs when the cancerous cells from a primary tumor become loose and travel through the lymph or blood system and establish a new tumor (metastatic tumor) somewhere else. Once it spreads, or metastasizes, the cancer is called metastatic melanoma.

NCBiotech previously awarded $110,000 in funding to advance the work of Claradele Founder Rukiyah Van Dross-Anderson, an East Carolina University Associate Professor of Pharmacology and Toxicology. She’s developing a topical treatment for melanoma and holds a patent for the compound that led to her starting Claradele.



Like what you've read?

Forward to a friend!

Don’t Miss Out on the Southeast’s Latest Entrepreneurial, Business, & Tech News!

Sign-up to get the Teknovation Newsletter in your inbox each morning!

  • This field is for validation purposes and should be left unchanged.


No, thanks!